Ediz Suha Calay

Harvard School of Public Health, Boston, MA, United States 
Obesity, diabetes, T2DM, physiology, fatty liver disease
"Ediz Calay"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tirosh A, Calay ES, Tuncman G, et al. (2019) The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans. Science Translational Medicine. 11
Burak MF, Inouye KE, White A, et al. (2015) Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes. Science Translational Medicine. 7: 319ra205
Yang L, Calay ES, Fan J, et al. (2015) METABOLISM. S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction. Science (New York, N.Y.). 349: 500-6
Calay ES, Hotamisligil GS. (2013) Turning off the inflammatory, but not the metabolic, flames. Nature Medicine. 19: 265-7
ten Freyhaus H, Calay ES, Yalcin A, et al. (2012) Stamp2 controls macrophage inflammation through nicotinamide adenine dinucleotide phosphate homeostasis and protects against atherosclerosis. Cell Metabolism. 16: 81-9
Yang L, Li P, Fu S, et al. (2010) Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metabolism. 11: 467-78
See more...